Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Advances in cellulose-based food packaging material move to testing phase of industrial production

Press release 28 January, 2021 VTT is testing Thermocell plastic film made of cellulose and fatty acids in the production of food packaging in cooperation with Arla Foods, Paulig, and Wipak.  Thermocell plastic material, which is made from renewable components, is to be used in the same way as fossil-based plastic. Thanks to the development work, many features of the film already meet the requirements of the food industry, and cooperation has advanced to the testing of industrial production.Renewable origin and recyclability of packaging materials are of increasing interest to both

Liseberg deploys new data centre solution from Proact for streamlined IT operations and enhanced security

Liseberg has assigned Proact to help modernise its IT infrastructure. Its new data centre solution, designed and delivered by Proact, comprises a hyperconverged system which integrates servers and storage, and a high-performance backup solution which also provides enhanced protection against cyberthreats.Following procurement, the amusement park Liseberg, Sweden’s largest tourist destination, has signed Proact as their partner for a major initiative to update its IT infrastructure. The key objectives for the investment are to simplify operations and administration of the data centre

Nexam Chemical Holding AB (publ) Year-End Report 1 January – 31 December 2020

Strong finish of 2020 with best quarter so farFourth quarter at a glance Significant events: · Continued profitable growth, +46% compared to the corresponding quarter in 2019. · Both Performance Chemical, + 70%, and Performance Masterbatch, + 26%, are growing compared to the corresponding quarter in 2019. · Good order intake during the quarter, indicates a good start to 2021. · New product series launched for the polyester fiber area. · Settlement reached with Uponor Innovation AB regarding patent rights for applications concerning polyethylene pipes applications. The

Wärtsilä's Board of Directors decided on a new share-based incentive scheme

Wärtsilä Corporation Stock Exchange Release 28 January 2021 at 9.00 a.m. (EET)Wärtsilä's Board of Directors decided on a new share-based incentive scheme The Board of Directors of Wärtsilä Corporation has decided on the establishment of a new share-based long-term incentive scheme for the company’s management and selected key employees. The incentive scheme comprises a Performance Share Plan (“PSP”). The objectives of the share-based long-term incentive scheme are to align the interests of Wärtsilä’s management and key employees with those of the company’s shareholders and, thus, to

Lagercrantz Interim Report 2020/21 Q3

Third quarter (1 October – 31 December 2020) · Net revenue totalled MSEK 1,078 (1,099). · Operating profit (EBITA) increased by 8 percent to MSEK 168 (156), equivalent to an operating margin of 15.6 percent (14.2). · Profit after financial items increased by 8 percent to MSEK 139 (129). · Profit after taxes increased by 6 percent to MSEK 111 (105) and earnings per share (after dilution and carried out split) amounted to SEK 0.54 (0.52). · Cash flow from operating activities increased to MSEK 226 (178). · Return on equity for the latest 12-month period amounted to 22

Cloetta AB interim report Q4: October – December 2020

Taking actions to mitigate the impact of COVID-19 as the previous sales recovery transitioned into a new slowdown during the quarter.·Net sales for the quarter decreased by 14.9 per cent to SEK 1,466m (1,722), including a negative effect of 2.6 per cent due to exchange rate fluctuations. · Sales of branded packaged products decreased organically by –3.6 per cent during the quarter, comprised of –1.4 per cent for October, –3.4 per cent for November, and –6.8 per cent for December. · Sales of pick & mix declined organically by –35.9 per cent during the quarter, comprised of –38.5

SAS and Apollo extend partnership in record contract

SAS and Apollo are expanding their partnership regarding charter flights in a contract which covers three summer and three winter seasons through to 2024, with an option for an extension of a further two years to 2026. The partnership with Apollo represents SAS’ largest contract with a charter operator and is worth around SEK 3.4 billion over the first three years.The contract means SAS remains the main partner for Apollo’s charter flights from Scandinavia for the duration of the contract. SAS will fly Apollo customers to and from 24 locations across Sweden, Denmark and Norway to 51

Orexo Q4 2020, incl. Full Year Report

ZUBSOLV® stable and strong EBIT, despite challenging market due to Covid-19  Q4 2020 highlights · Total net revenues of SEK 159.2 m (238.1 last year, 196.2 m excl. Abstral® EU and US) · Net earnings of SEK -49.6 m (38.9) · EBITDA of SEK 1.0 m (85.8) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 143.1 m (190.5), EBIT of SEK 94.4 m (95.5) · Cash flow from operating activities of SEK -11.2 m (60.2), cash balance of SEK 505.3 m (816.8) · Secured a preferred position for ZUBSOLV® as the only branded product on national commercial and Medicare Part D formularies

SRV Group Plc: Proposals of the Shareholders’ Nomination Board to the Annual General Meeting 2021

SRV GROUP PLC     STOCK EXCHANGE RELEASE     28 JANUARY 2021      09:00 EET SRV Group Plc: Proposals of the Shareholders’ Nomination Board to the Annual General Meeting 2021 SRV Group Plc’s Annual General Meeting 2020 established a Shareholders’ Nomination Board to prepare annually proposals concerning the composition and remuneration of the Board of Directors. SRV Group Plc’s Shareholders’ Nomination Board proposes to the Annual General Meeting of SRV Group Plc that five members will be elected to the Board of Directors. Shareholders’ Nomination Board proposes that present

Statement by the Board of Directors of Recipharm regarding the public offer from Roar BidCo

The Board of Directors unanimously recommends the shareholders and holders of convertible bonds to accept the offer from Roar BidCo. This statement is made by the board of directors of Recipharm AB (publ) (“Recipharm”) pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the ”Takeover Rules”). The Offer On 14 December 2020, EQT IX, through Roar BidCo AB (the “Offeror”), announced a public offer of SEK 220 per share to the shareholders of Recipharm after having submitted an indicative offer to the board of SEK 196 per share at an initial stage. Today, 28 January 2021, the

Roar BidCo AB announces an increased recommended offer to the shareholders and Holders of Convertible Bonds in Recipharm AB (publ) that cannot be increased

The increased consideration amounts to SEK 232 per share and SEK 1,504,295 per Convertible Bond. On 14 December 2020, EQT IX[1 ]("EQT IX"), through Roar BidCo AB[2][ ]("Roar BidCo"), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the "Convertible Bonds") ("Holders of Convertible Bonds") in Recipharm AB (publ) ("Recipharm" or the "Company") to tender all their shares[3] and Convertible Bonds to Roar BidCo for SEK 220 in cash per share and SEK 1,427,010 in cash per SEK 1,000,000 in aggregate principal amount of Convertible Bonds (the "

Recipharm AB publishes report for the fourth quarter and full year 2020

October – December 2020 · Net sales amounted to SEK 2,812 million (1,981), an increase of 42% · EBITA increased by 65% and amounted to SEK 378 million (230) corresponding to an EBITA margin of 13.5% (11.6) · Operating profit (EBIT) amounted to SEK 339 million (117) and was affected by non-recurring items of SEK +54 million (-52) · Profit after tax amounted to SEK 223 million (90) corresponding to a net margin of 7.9% (4.5) · Earnings per share amounted to SEK 2.20 (1.32) before dilution and SEK 2.19 (1.32) after dilution. Core EPS amounted to SEK 1.40 (2.55) · Leverage

BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in relapsed non-Hodgkin’s lymphoma patients

· Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore activity of rituximab in non-Hodgkin’s lymphoma patients who have relapsed after treatment with rituximab · Long-lasting complete responses observed in two patients beyond 12 months · Key opinion leader (KOL) call to discuss results today, January 28, at 5.30 p.m. CET (11:30 a.m. ET)   Lund, Sweden – January 28, 2021 – BioInvent International AB (“BioInvent”) (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-

Notice to convene the Annual General Meeting of Wärtsilä Corporation

Wärtsilä Corporation, stock exchange release, 28 January 2021 at 8.40 am EETNotice to convene the Annual General Meeting of Wärtsilä Corporation Notice is given to the shareholders of Wärtsilä Corporation of the Annual General Meeting to be held on Thursday 4 March 2021 at 3 p.m. EET at the Company’s headquarters at the address Hiililaiturinkuja 2, 00180 Helsinki, Finland. The shareholders of the Company may participate in the meeting and exercise their shareholder rights only by voting in advance and by presenting counterproposals and asking questions in advance. Instructions for

Wärtsilä’s Financial Statements Bulletin January–December 2020

Wärtsilä Corporation, Financial Statements Bulletin January–December 2020, 28 January 2021 at 8:30 a.m. local timeWärtsilä’s Financial Statements Bulletin January–December 2020 This release is a summary of Wärtsilä’s Financial Statements Bulletin January–December 2020. The complete report is attached to this release as a pdf file. It is also available on the company website at www.wartsila.com. 2020 – a year characterised by COVID-19 related uncertainty Highlights of October–December 2020 · Order intake decreased by 28% to EUR 1,118 million (1,555) · Net sales decreased by

Nordic Paper Year-end report January – December 2020

Quarterly results October - December ·Net sales decreased by 9% to SEK 670m (738), excluding currency effects the decrease was 3% ·EBITDA was SEK 144m (65), corresponding to an EBITDA margin of 21.4% (8.8) ·Maintenance stop in Bäckhammar affected the quarterly operating result negatively by SEK 9m (57) ·IPO costs in the quarter was SEK 2m (-) ·Operating profit was SEK 113m (40), corresponding to an operating margin of 16.8% (5.4) ·Net result for the period amounted to SEK 75m (32) ·Cash flow from operating activities was SEK 17m (14) ·

Gränges’ year-end report January–December 2020

Strong fourth quarter concluded a challenging yet productive year Fourth quarter 2020 · The acquisition of Aluminium Konin has been completed and is consolidated from November. · Sales volume increased by 32.6 per cent to 103.3 ktonnes (77.9). Net sales increased to SEK 3,149 million (2,682). Excluding acquisitions sales volume increased by 13.9 per cent and net sales was SEK 2,761 million. · Adjusted operating profit increased to SEK 193 million (144) and adjusted operating profit per tonne was 1.9 kSEK (1.9). Excluding acquisitions, adjusted operating profit increased to SEK

CapMan to publish its 2020 Financial Statements Bulletin on Thursday 4 February 2021

CapMan Plc press release                              28 January 2021 at 8.30 a.m. EET CapMan to publish its 2020 Financial Statements Bulletin on Thursday 4 February 2021 CapMan will publish its 2020 Financial Statements Bulletin on Thursday 4 February 2021 around 8.30 a.m. EET. The company will present the results for the review period over a webcast press conference starting at 9.00 a.m. EET accessible at https://capman.videosync.fi/2020-q4-results. The conference will be held in English. The report and presentation material will be available at CapMan’s website

Elisa’s Financial Statements Release 2020

ELISA FINANCIAL STATEMENT RELEASE 28 JANUARY 2021 AT 8:30 AMFourth quarter 2020 financial highlights · Revenue increased by EUR 11m to EUR 498m, mainly due to growth in telecom and digital services, as well as equipment sales. · Mobile service revenue increased by 0.7 per cent to EUR 209m. · EBITDA grew by EUR 3m to EUR 171m. · Comparable EBIT increased by EUR 3m to EUR 103m. · Comparable cash flow increased by EUR 44m to EUR 99m, mainly due to a change in net working capital and lower capital expenditure. · Mobile post-paid ARPU increased from the previous quarter to

UPM’s growth plans in biofuels progress to the next stage

(UPM, Helsinki, 28 January 2021 at 08:15 EET) – UPM moves forward with biofuels growth plans and starts the basic engineering phase of a next generation biorefinery. The potential biorefinery would have an annual capacity of 500,000 tonnes of high-quality renewable fuels including sustainable jet fuel. The products would significantly reduce carbon footprint in the road transport and aviation, as well as replace fossil raw materials with renewable alternatives in chemicals and bioplastics. “The planned biorefinery would scale up UPM’s successful biofuels business to a new level. At the

Archer Limited: Q4 2020 trading update and 2021 financial outlook

Hamilton, Bermuda (January 28, 2021) Archer will today host an analyst call where we will share our preliminary financials for Q4 2020 and our outlook for 2021. Trading update Q4 2020 Based on preliminary unaudited financials, Archer Limited expects to report the following key financials for Q4 2020: · Revenue of $211 million was up 15% compared to third quarter · EBITDA reported of $19.2 million was up 23% compared to third quarter · EBITDA before exceptional items of $23.3 million · Net interest bearing debt of $504 million · Robust liquidity of $110 million

Interim report for the fourth quarter and full-year 2020

NCC delivers steady progress“NCC’s project portfolio has improved, which is reflected in our earnings. During this quarter, we also took measures to strengthen our industrial operations,” says Tomas Carlsson, President and CEO of NCC. · The contracting business has steady progress. Improved operating profit, healthy orders received and strong order backlog in Building Sweden and Building Nordics. Somewhat lower orders received in Infrastructure due to more early involvement projects and a lower tender outcome · The plan for improved earnings in the Industry business area that was

Understanding how genetic motifs conduct "the music of life"

Our genetic codes control not only which proteins our cells produce, but also – to a great extent – in what quantity. This ground-breaking discovery, applicable to all biological life, was recently made by systems biologists at Chalmers University of Technology, Sweden, using supercomputers and artificial intelligence. Their research, which could also shed new light on the mysteries of cancer, was recently published in the scientific journal Nature Communications. DNA molecules contain instructions for cells for producing various proteins. This has been known since the middle

There are no items matching the current filter
There are no more items matching the current filter
Back to top